New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
BioVie Inc. (BIVI) vs Lexaria Bioscience Corp. (LEXX)
- BioVie Inc. BIVI 0.80 −12.09%
- Lexaria Bioscience Corp. LEXX 4.03 −10.24%
BioVie Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. BioVie Inc. and Lexaria Bioscience Corp. are of similar size ($9.8M and $9.5M). BioVie Inc. has the higher net margin (0.00% vs −1,686.1%) and the higher return on invested capital (0.00% vs −662.6%). Across the 12 metrics below, BioVie Inc. leads on 8 and Lexaria Bioscience Corp. on 4.
Valuation
Profitability
| Metric | BIVI | LEXX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 99.62% | 70.18% |
| Operating margin | 0.00% | (1,683.06%) | 0.00% |
| Net margin | 0.00% | (1,686.05%) | 0.00% |
| Free cash flow margin | 0.00% | (1,494.56%) | 0.00% |
| Return on equity | (143.66%) | (162.60%) | (51.58%) |
| Return on assets | (119.34%) | (134.20%) | (45.91%) |
| Return on invested capital | 0.00% | (662.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack